Position in VTRS
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$950,279
+$69,093 QoQ
Shares Held
70,339
-0.6% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026QUADRANT CAPITAL GROUP LLC holds $18,364,187 across 30 Drug Manufacturers - Specialty & Generic names. VTRS ranks #6 (5.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RDY |
Dr Reddys Laboratories Ltd
|
489,799 | $6,783,716 | |
| 2 | TAK |
Takeda Pharmaceutical Co Ltd
|
127,505 | $2,361,392 | |
| 3 | ZTS |
Zoetis Inc.
|
17,457 | $2,063,591 | |
| 4 | HLN |
Haleon plc
|
118,327 | $1,184,453 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
7,689 | $1,012,948 | |
| 6 | VTRS |
Viatris Inc
This page
|
70,339 | $950,279 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
24,340 | $733,120 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
7,890 | $598,456 |
All Filings in VTRS
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $950,279 | 70,339 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $881,186 | 70,778 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $697,979 | 70,503 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $627,993 | 70,324 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $11,523 | 1,323 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $22,123 | 1,777 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $21,617 | 1,862 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $20,133 | 1,894 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $22,614 | 1,894 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $19,992 | 1,846 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $31,561 | 3,201 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $28,622 | 2,868 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $22,126 | 2,300 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $24,051 | 2,161 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $26,769 | 3,142 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $37,283 | 3,561 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $39,918 | 3,669 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $51,089 | 3,776 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $43,170 | 3,186 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $44,241 | 3,096 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $69,640 | 4,985 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $101,345 | 5,408 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||